BioVie Inc.
BIVI · NASDAQ
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Market Cap | $14 | $18 | $140 | $36 |
| - Cash | $18 | $24 | $19 | $19 |
| + Debt | $0 | $6 | $14 | $12 |
| Enterprise Value | -$4 | $1 | $135 | $29 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$17 | -$32 | -$46 | -$27 |
| % Margin | – | – | – | – |
| Net Income | -$18 | -$32 | -$50 | -$26 |
| % Margin | – | – | – | – |
| EPS Diluted | -12.12 | -73.05 | -154.7 | -106 |
| % Growth | 83.4% | 52.8% | -45.9% | – |
| Operating Cash Flow | -$19 | -$28 | -$40 | -$19 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$19 | -$28 | -$40 | -$19 |